Cardiol Therapeutics Inc. Nonderivative Financial Liabilities Undiscounted Cash Flows
Cardiol Therapeutics Inc. (CRDL) had Nonderivative Financial Liabilities Undiscounted Cash Flows of CAD 4.98 million as of 2021-12-31, per its 40-F/A filed 2022-04-20.
Discontinued › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2022-04-20
- 2021-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows 4.98M CAD.
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2021-12-31 | 4.98M CAD 40-F/A · filed 2022-04-20 |